Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.

Bausch + Lomb Introduces the Putterman Consecutive CDCR Set

ALISO VIEJO, Calif. — Bausch + Lomb Instruments for Ophthalmology, Ear, Nose, Throat and Plastic Surgery announced the launch of the Putterman Consecutive Conjunctivodacryocystorhinostomy Set in the United States. Designed by Dr. Allen M. Putterman of Chicago, Illinois, this set is designed to form the CDCR osteum and place the bypass tube without withdrawal and reinsertion of instruments during each step of the procedure.

The set includes three instruments: a needle, trephine and probe. The needle is designed to create the initial track with the trephine used to slide over the needle to create the osteum. The needle is removed and the Bowman-type probe is inserted through the trephine. The trephine is then removed and the probe is used to measure the distance from medial canthus to nasal septum.

The probe features marks in 5.0 mm intervals from the tip to 15.0 mm, in 1.0 mm intervals from 15.0 mm to 25.0 mm, and again in 5.0 mm intervals from 25.0 mm to 35.0 mm.

For more information, to request a quote, or to place an order online, visit the Bausch + Lomb Instruments for Ear, Nose, Throat and Plastic Surgery web site at You may also contact Bausch + Lomb’s customer service support center at 1-800-338-2020 from 8:00 a.m. to 8:00 p.m. EST.

# # #

About Bausch + Lomb
Bausch + Lomb is one of the best-known and most respected healthcare companies in the world. Its core businesses include contact lenses and lens care products, opthalmic surgical devices and instruments, and ophthamic pharmaceuticals. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at

Actions: E-mail | Permalink |